Cargando…
HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson’s Disease
HSD17B13 encodes hydroxysteroid 17-β dehydrogenase 13, a novel liver lipid-droplet associated protein that is involved in the regulation of lipid biosynthetic processes. A protein-truncating HSD17B13 variant (rs72613567) was shown to protect individuals from alcoholic and non-alcoholic liver disease...
Autores principales: | Ferenci, Peter, Pfeiffenberger, Jan, Stättermayer, Albert Friedrich, Stauber, Rudolf E., Willheim, Claudia, Weiss, Karl H., Munda-Steindl, Petra, Trauner, Michael, Schilsky, Michael, Zoller, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001574/ https://www.ncbi.nlm.nih.gov/pubmed/32039348 http://dx.doi.org/10.1016/j.jhepr.2019.02.007 |
Ejemplares similares
-
Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
por: Paternostro, Rafael, et al.
Publicado: (2020) -
The dilemma to diagnose Wilson disease by genetic testing alone
por: Stättermayer, Albert Friedrich, et al.
Publicado: (2019) -
Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease
por: Merle, Uta, et al.
Publicado: (2010) -
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2021) -
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)